Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)

EGX:RMDA Balance Sheet

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	42.56	64.69	52.36	66.96	14	13.23
Short-Term Investments	59.55	189.7	260.9	361.86	468.01	469.35
Cash & Short-Term Investments	102.1	254.39	313.25	428.82	482.01	482.58
Cash Growth	-70.20%	-18.79%	-26.95%	-11.04%	-0.12%	-6.99%
Accounts Receivable	1,388	791.26	353.74	276.6	265.96	238.41
Other Receivables	20.78	103.43	72.16	22.6	25.2	33.11
Receivables	1,409	1,582	1,344	923.28	684.61	666.63
Inventory	918.53	751.34	303.26	348.41	259.4	305.48
Prepaid Expenses	294.55	4.29	2.21	2.83	0.99	0.91
Other Current Assets	93.84	544.65	60.33	55.14	48.64	40.98
Total Current Assets	2,818	3,137	2,023	1,758	1,476	1,497
Property, Plant & Equipment	625.65	621.52	606.05	556.98	554.99	538.16
Other Intangible Assets	998.15	552.79	589.27	457.57	389.66	214.57
Total Assets	4,443	4,311	3,218	2,773	2,420	2,249
Accounts Payable	398.74	264.36	102.41	120.25	61.53	46.93
Accrued Expenses	-	115.09	76.44	62.92	37.31	21.18
Short-Term Debt	1,720	1,555	1,098	910.18	842.6	823.75
Current Portion of Long-Term Debt	-	-	-	-	21.95	58.85
Current Portion of Leases	3.4	4.48	4.81	3.66	3.13	2.6
Current Income Taxes Payable	113.73	98.78	60.59	53.71	33.49	18.31
Other Current Liabilities	14.96	117.77	30.67	31.23	22.05	18.71
Total Current Liabilities	2,251	2,155	1,373	1,182	1,022	990.33
Long-Term Debt	-	-	-	-	-	29.55
Long-Term Leases	6.77	7.19	11.7	16.34	12.26	14.81
Long-Term Deferred Tax Liabilities	66.44	77.28	58.23	51.56	40.5	31.06
Total Liabilities	2,324	2,240	1,443	1,250	1,075	1,066
Common Stock	375.87	378.23	375	250	250	192.15
Additional Paid-In Capital	-	327.51	377.7	397.52	486.97	486.97
Retained Earnings	613.3	1,351	1,022	921.68	610.87	505.79
Treasury Stock	-	-26.23	-26.23	-65.93	-	-
Comprehensive Income & Other	13.31	13.31	14.21	15.31	0.28	0.28
Total Common Equity	1,002	2,044	1,763	1,519	1,348	1,185
Minority Interest	-	27.38	12.94	4.59	-2.62	-1.62
Shareholders' Equity	1,002	2,072	1,775	1,523	1,345	1,184
Total Liabilities & Equity	3,326	4,311	3,218	2,773	2,420	2,249
Total Debt	1,730	1,566	1,114	930.18	879.94	929.56
Net Cash (Debt)	-1,628	-1,312	-801.18	-501.37	-397.93	-446.98
Net Cash Per Share	-1.19	-0.87	-0.53	-0.34	-0.26	-0.29
Filing Date Shares Outstanding	1,145	1,503	1,491	1,491	1,523	1,523
Total Common Shares Outstanding	1,145	1,503	1,491	1,478	1,523	1,523
Working Capital	567.12	981.82	650.11	576.53	453.59	506.26
Book Value Per Share	0.88	1.36	1.18	1.03	0.89	0.78
Tangible Book Value	4.32	1,491	1,173	1,061	958.45	970.62
Tangible Book Value Per Share	0.00	0.99	0.79	0.72	0.63	0.64
Land	-	18.64	18.64	18.64	18.64	18.64
Buildings	-	294.77	288.43	279.17	273.34	257.23
Machinery	-	646.31	585.04	533.6	491.55	462.1
Construction In Progress	-	33.46	38.09	12.86	27.04	26.59

Source: S&P Global Market Intelligence. Standard template. Financial Sources.